Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Homozygous Familial Hypercholesterolemia
Homozygous Familial Hypercholesterolemia
FDA expands use of Regeneron's HoFH drug Evkeeza to kids 5 and up
Fierce Pharma
Wed, 03/22/23 - 11:14 am
Regeneron
Evkeeza
pediatric
Homozygous Familial Hypercholesterolemia
FDA
Regeneron's Evkeeza, carrying big price tag, wins FDA approval in ultra-rare cholesterol disease
Fierce Pharma
Thu, 02/11/21 - 10:36 pm
Regeneron
Evkeeza
Homozygous Familial Hypercholesterolemia
FDA
Regeneron's Praluent sidekick nabs speedy FDA review, with February PDUFA date
Fierce Biotech
Wed, 08/12/20 - 10:53 am
Regeneron
evicanumab
FDA
Homozygous Familial Hypercholesterolemia
Regeneron drug proves effective in genetic form of high cholesterol
Stat
Wed, 08/14/19 - 10:14 am
Regeneron
Homozygous Familial Hypercholesterolemia
evinacumab
A New Class of Cardiovascular Drug
The Chairman's Blog
Fri, 09/5/14 - 10:13 am
Capstone Therapeutics
AEM-28
Homozygous Familial Hypercholesterolemia
Aegerion reports results from Phase 3 study of Juxtapid
Yahoo/Fly on the Wall
Tue, 11/19/13 - 07:27 am
Aegerion
Juxtapid
Homozygous Familial Hypercholesterolemia
Isis: FDA Approval Of Kynamro Promises A Bright Future For Company
Seeking Alpha
Fri, 02/1/13 - 11:40 am
FDA
Kynamro
Isis Pharmaceuticals
Sanofi
Genzyme
Homozygous Familial Hypercholesterolemia
FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
Forbes
Wed, 01/30/13 - 10:38 am
mipomersen
Kynamro
Isis Pharmaceuticals
Homozygous Familial Hypercholesterolemia
Genzyme
FDA
Aegerion says FDA approves Juxtapid, a treatment for a rare high cholesterol disorder
Yahoo/AP
Mon, 12/24/12 - 10:30 am
lomitapide
Homozygous Familial Hypercholesterolemia
Juxtapid
Aegerion
FDA
Aegerion Hits New High
Motley Fool
Sat, 12/15/12 - 12:54 pm
Aegerion
lomitapide
Homozygous Familial Hypercholesterolemia
cholesterol
Genzyme, Isis say CHMP adopts negative opinion on KYNAMRO
Yahoo/Fly on the Wall
Fri, 12/14/12 - 11:47 am
Genzyme
Isis Pharmaceuticals
Kynamro
CHMP
Homozygous Familial Hypercholesterolemia
Aegerion's Lomitapide - FDA Approval, Strong Launch, Stock Price Increase Anticipated
Seeking Alpha
Wed, 10/24/12 - 10:58 am
lomitapide
FDA
Aegerion
Homozygous Familial Hypercholesterolemia
Processing Aegerion Pharmaceuticals' Recent Rally
Seeking Alpha
Fri, 10/19/12 - 10:57 am
Aegerion
lomitapide
Homozygous Familial Hypercholesterolemia
Isis Pharma/Genzyme FDA Panel Live Blog
TheStreet.com
Thu, 10/18/12 - 11:39 am
Genzyme
FDA
Sanofi
Isis Pharmaceuticals
advisory panels
Aegerion
Homozygous Familial Hypercholesterolemia
mipomersen
Isis Falls on Concerns Over Abnormal Growths With Kynamro
Bloomberg
Tue, 10/16/12 - 11:39 am
Isis Pharmaceuticals
Kynamro
mipomersen
Homozygous Familial Hypercholesterolemia
FDA panel says lomitapide data supports 'appropriate use'
Yahoo/Fly on the Wall
Mon, 10/15/12 - 11:11 am
FDA
lomitapide
advisory panels
HoFH
Homozygous Familial Hypercholesterolemia
Aegerion
Aegerion Pharma announces FDA acceptance of NDA for review of lomitapide
The Fly on the Wall
Mon, 04/30/12 - 10:14 am
FDA
lomitapide
Aegerion
Homozygous Familial Hypercholesterolemia
Genzyme-Isis File Kynamro NDA
Yahoo/Zacks
Wed, 04/4/12 - 09:41 am
Isis
Genzyme
Kynamro
Homozygous Familial Hypercholesterolemia
Genzyme sends drug for rare cholesterol disorder to FDA
Bizjournals.com
Fri, 03/30/12 - 11:05 am
FDA
Genzyme
Kynamro
Homozygous Familial Hypercholesterolemia